University of Leeds Featured PhD Programmes
Imperial College London Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
The Francis Crick Institute Featured PhD Programmes
The Hong Kong Polytechnic University Featured PhD Programmes
"drug" AND "resistance"×
10 miles

drug resistance PhD Projects, Programs & Scholarships

We have 71 drug resistance PhD Projects, Programs & Scholarships

  • "drug" AND "resistance" ×
  • clear all
Order by 
Showing 1 to 10 of 71
  FULLY FUNDED PhD: Studying drug resistance in biliary cancer through the investigation of the cross-talk between cancer and micro-environment
  Dr C Braconi
Application Deadline: 8 November 2019

Funding Type

PhD Type

*** To apply, click the ’VISIT WEBSITE’ button ***. Biliary cancer are highly chemo-resistant. Drug resistance is the result of intrinsic properties of cancer cells, as well as of the cross talk between cancer and other cell types.
  Molecular mechanisms of acquired chemotherapy resistance in colorectal cancer and their implications for novel therapeutics development
  Dr M Gerlinger, Dr J Choudhary
Application Deadline: 17 November 2019

Funding Type

PhD Type

The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes. We are committed to attracting and developing the best minds in the world to join us in our mission—to make the discoveries that defeat cancer.
  Exploring molecular mechanisms of drug resistance and pathogenicity in the filamentous fungus Aspergillus fumigatus
  Dr M Bromley, Prof P Bowyer
Applications accepted all year round

Funding Type

PhD Type

A. fumigatus is the primary etiological agent of invasive aspergillosis, a disease that primarily affects individuals who are immunocompromised, and causes 200k life threatening infections annually.
  Understanding drug-resistance in myeloid cancer
  Dr P Laslo
Applications accepted all year round

Funding Type

PhD Type

Under pathogenic challenges, cells of the innate system become epigenetically reprogrammed and establish immune memory.
  Using synthetic biology to understand the evolution of antibiotic resistance
  Dr M Lagator, Dr C Knight
Applications accepted all year round

Funding Type

PhD Type

Imagine an architect, tasked with converting an old stadium into a building with a different function, without demolishing it.
  Nanotechnologies for cancer: developing new polymer-drug conjugates for the treatment of a range of cancers
  Dr F Greco, Prof H Osborn
Applications accepted all year round

Funding Type

PhD Type

Polymer anticancer-drug conjugates are drug delivery systems in which a low molecular weight anticancer agent is covalently conjugated to a water-soluble polymeric carrier.
  TRANS-CASPS: Translational studies in Cedrianib in Alveolar Soft Part Sarcoma (CASPS) trial.
  Dr C Jones, Dr P Huang
Application Deadline: 17 November 2019

Funding Type

PhD Type

The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes. We are committed to attracting and developing the best minds in the world to join us in our mission—to make the discoveries that defeat cancer.
  The role of Efflux in Antibiotic Resistance of Clinically Relevant Pathogens
  Dr J Blair
Applications accepted all year round

Funding Type

PhD Type

Antibiotics underpin all of modern medicine; they are used to treat bacterial infections, and to prevent infections after surgery and in patients with a suppressed immune system such as those undergoing cancer chemotherapy or organ transplantation.
  Deciphering the regulation of fission yeast phenotypic heterogeneity by external conditions
  Research Group: Quantitative Gene Expression
  Dr S Marguerat
Application Deadline: 1 December 2019

Funding Type

PhD Type

Phenotypic cell-to-cell variability is a fundamental determinant of microbial fitness that contributes to stress adaptation and drug resistance.
  Tumour microenvironment and colorectal cancer development: understanding the mechanisms of the tumour growth
  Prof D Kerr, Dr S Cai
Application Deadline: 10 January 2020

Funding Type

PhD Type

Our group has conducted a series of international adjuvant trials of chemotherapy for colorectal cancer (Kerr RS. et al, (2016), Lancet Oncol, 17, 1543 – 1557).
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.